125 related articles for article (PubMed ID: 1804770)
1. A rabies-specific human monoclonal antibody that protects mice against lethal rabies.
Enssle K; Kurrle R; Köhler R; Müller H; Kanzy EJ; Hilfenhaus J; Seiler FR
Hybridoma; 1991 Oct; 10(5):547-56. PubMed ID: 1804770
[TBL] [Abstract][Full Text] [Related]
2. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
Turki I; Hammami A; Kharmachi H; Mousli M
Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293
[TBL] [Abstract][Full Text] [Related]
3. [Production of monoclonal antibodies against a wild strain of rabies virus].
Akacem O; Benmansour A; Coulon P; Brahimi M; Benhassine M
Arch Inst Pasteur Alger; 1992; 58():283-90. PubMed ID: 1309144
[TBL] [Abstract][Full Text] [Related]
4. Negative effects of a disulfide bond mismatch in anti-rabies G protein single-chain antibody variable fragment FV57.
Duan Y; Gu T; Zhang X; Jiang C; Yuan R; Li Z; Wang D; Chen X; Wu C; Chen Y; Wu Y; Kong W
Mol Immunol; 2014 Jun; 59(2):136-41. PubMed ID: 24598312
[TBL] [Abstract][Full Text] [Related]
5. Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies.
Prosniak M; Faber M; Hanlon CA; Rupprecht CE; Hooper DC; Dietzschold B
J Infect Dis; 2003 Jul; 188(1):53-6. PubMed ID: 12825170
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates.
Sloan SE; Hanlon C; Weldon W; Niezgoda M; Blanton J; Self J; Rowley KJ; Mandell RB; Babcock GJ; Thomas WD; Rupprecht CE; Ambrosino DM
Vaccine; 2007 Apr; 25(15):2800-10. PubMed ID: 17240489
[TBL] [Abstract][Full Text] [Related]
7. Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein.
Lafon M; Edelman L; Bouvet JP; Lafage M; Montchâtre E
J Gen Virol; 1990 Aug; 71 ( Pt 8)():1689-96. PubMed ID: 2391499
[TBL] [Abstract][Full Text] [Related]
8. Evidence from the anti-idiotypic network that the acetylcholine receptor is a rabies virus receptor.
Hanham CA; Zhao F; Tignor GH
J Virol; 1993 Jan; 67(1):530-42. PubMed ID: 7677960
[TBL] [Abstract][Full Text] [Related]
9. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ
Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
[TBL] [Abstract][Full Text] [Related]
10. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.
Bakker AB; Marissen WE; Kramer RA; Rice AB; Weldon WC; Niezgoda M; Hanlon CA; Thijsse S; Backus HH; de Kruif J; Dietzschold B; Rupprecht CE; Goudsmit J
J Virol; 2005 Jul; 79(14):9062-8. PubMed ID: 15994800
[TBL] [Abstract][Full Text] [Related]
11. Common and different antigenic properties of the rabies virus glycoprotein of strains SAD-Vnukovo and Pitman-Moore.
Máciková I; Dedek L; Vrzal V; Kontseková E; Kontsek P; Ciampor F; Novák M
Acta Virol; 1992 Dec; 36(6):541-50. PubMed ID: 1284868
[TBL] [Abstract][Full Text] [Related]
12. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies.
Wiktor TJ; Macfarlan RI; Foggin CM; Koprowski H
Dev Biol Stand; 1984; 57():199-211. PubMed ID: 6526138
[TBL] [Abstract][Full Text] [Related]
13. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs.
Zhang S; Liu Y; Zhang F; Hu R
Vaccine; 2009 Mar; 27(15):2108-13. PubMed ID: 19356613
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
[TBL] [Abstract][Full Text] [Related]
15. Production of rabies neutralizing antibody in hen's eggs using a part of the G protein expressed in Escherichia coli.
Motoi Y; Sato K; Hatta H; Morimoto K; Inoue S; Yamada A
Vaccine; 2005 Apr; 23(23):3026-32. PubMed ID: 15811649
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology.
Zhao XL; Yin J; Chen WQ; Jiang M; Yang G; Yang ZH
Microbiol Immunol; 2008 Feb; 52(2):89-93. PubMed ID: 18380806
[TBL] [Abstract][Full Text] [Related]
17. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.
Goudsmit J; Marissen WE; Weldon WC; Niezgoda M; Hanlon CA; Rice AB; Kruif Jd; Dietzschold B; Bakker AB; Rupprecht CE
J Infect Dis; 2006 Mar; 193(6):796-801. PubMed ID: 16479514
[TBL] [Abstract][Full Text] [Related]
18. Novel monoclonal antibodies that bind to wild and fixed rabies virus strains.
Zanluca C; Aires LR; Mueller PP; Santos VV; Carrieri ML; Pinto AR; Zanetti CR
J Virol Methods; 2011 Jul; 175(1):66-73. PubMed ID: 21536074
[TBL] [Abstract][Full Text] [Related]
19. Protection against rabies in mice by a cytotoxic T cell clone recognizing the glycoprotein of rabies virus.
Kawano H; Mifune K; Ohuchi M; Mannen K; Cho S; Hiramatsu K; Shichijo A
J Gen Virol; 1990 Feb; 71 ( Pt 2)():281-7. PubMed ID: 2307962
[TBL] [Abstract][Full Text] [Related]
20. A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies.
Borhani K; Ajorloo M; Bamdad T; Mozhgani SH; Ghaderi M; Gholami AR
Arch Iran Med; 2015 Apr; 18(4):223-7. PubMed ID: 25841942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
